Shigekiyo Matsumoto

Dr. Shigekiyo Matsumoto

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2016 in Journal of Intensive Care
Verified
Journal Article
Open access
PDF file
JMJunichi Michikoshi
Junichi Michikoshi
SMShigekiyo Matsumoto
Shigekiyo Matsumoto
HMHiroshi Miyawaki
Hiroshi Miyawaki
HNHarushi Niu
Harushi Niu
KSKatsuhiro Seo
Katsuhiro Seo
TKTakaaki Kitano
Takaaki Kitano
The management of tracheal tube cuff pressure in patients receiving mechanical ventilation is important for the prevention of ventilator-associated pneumonia. Currently, cuff pressure is intermittently monitored with a pressure gauge and adjusted when necessary in a routine practice. However, this method results in wide variations in pressure, and adequate management is difficult due to the spontaneous release of air from the cuff, which reduces cuff pressure. In order to continuously maintain a uniform cuff pressure, we developed a new automated cuff pressure controller and compared its properties with existing devices. The effectiveness of the new device was assessed with a model trachea/lung and tracheal tube by measuring cuff pressure while on mechanical ventilation. An electrically powered automatic cuff controller or manual cuff pressure control was used for comparison purposes. The effectiveness of the new device was also examined in patients receiving mechanical ventilation by continuously measuring cuff pressure for a 24-h period. Cuff pressure was uniformly maintained with the new device. Moreover, in the clinical setting, variation in pressure from the set pressure was minimal with both the new device and existing device, relative to the intermittent monitoring method. This suggests that, as with the existing device, uniform cuff pressure management is possible with the new device. Our results demonstrate the ability of the new cuff pressure controller to manage cuff pressure without the need of a power source, highlighting its potential utility in clinical settings.

17 July 2021 in Chemosensors
Verified
Journal Article
Open access
PDF file
Seung-Woo LeeSeung-Woo Lee
Seung-Woo Lee
SASoad Ahmed
Soad Ahmed
Tao WangTao Wang
Tao Wang
YPYeawon Park
Yeawon Park
SMSota Matsuzaki
Sota Matsuzaki
SJSteve James
Steve James
Creatinine (CR) is a representative metabolic byproduct of muscles, and its sensitive and selective detection has become critical in the diagnosis of kidney diseases. In this study, poly(acrylic acid) (PAA)-assisted molecularly imprinted (MI) TiO2 nanothin films fabricated via liquid phase deposition (LPD) were employed for CR detection. The molecular recognition properties of the fabricated films were evaluated using fiber optic long period grating (LPG) and quartz crystal microbalance sensors. Imprinting effects were examined compared with nonimprinted (NI) pure TiO2 and PAA-assisted TiO2 films fabricated similarly without a template. In addition, the surface modification of the optical fiber section containing the LPG with a mesoporous base coating of silica nanoparticles, which was conducted before LPD-based TiO2 film deposition, contributed to the improvement of the sensitivity of the MI LPG sensor. The sensitivity and selectivity of LPGs coated with MI films were tested using CR solutions dissolved in different pH waters and artificial urine (near pH 7). The CR binding constants of the MI and NI films, which were calculated from the Benesi–Hildebrand plots of the wavelength shifts of the second LPG band recorded in water at pH 4.6, were estimated to be 67 and 7.8 M−1, respectively, showing an almost ninefold higher sensitivity in the MI film. The mechanism of the interaction between the template and the TiO2 matrix and the film composition was investigated via ultraviolet–visible and attenuated total reflectance Fourier-transform infrared spectroscopy along with X-ray photoelectron spectroscopy analysis. In addition, morphological studies using a scanning electron microscope and atomic force microscope were conducted. The proposed system has the potential for practical use to determine CR levels in urine samples. This LPG-based label-free CR biosensor is innovative and expected to be a new tool to identify complex biomolecules in terms of its easy fabrication and simplicity in methodology.

13 March 2011 in Journal of Anesthesia
Verified
Journal Article
Closed access
PDF file
SMShigekiyo Matsumoto
Shigekiyo Matsumoto
SHSatoshi Hagiwara
Satoshi Hagiwara
JKJunya Kusaka
Junya Kusaka
RHRie Hasegawa
Rie Hasegawa
HNHitomi Nonaka
Hitomi Nonaka
TNTakayuki Noguchi
Takayuki Noguchi

3 May 2025 in The Journal of Vascular Access
Verified
Journal Article
Closed access
SNShoko Nakamura
Shoko Nakamura
TUTetsuya Uchino
Tetsuya Uchino
SMShigekiyo Matsumoto
Shigekiyo Matsumoto
Radial artery catheterization is commonly performed using the pulse palpation method. However, anatomical variations, such as the persistent median artery—an embryonic structure that may persist into adulthood—can complicate this procedure. A 47-year-old female scheduled for laparoscopic surgery required radial artery catheterization for hemodynamic monitoring. Multiple attempts to place a 22-gauge catheter in the left radial artery were unsuccessful. During the procedure, a pulsating vessel was identified on the ulnar side of the radial artery. Vascular visualization devices revealed the presence of a persistent median artery, accompanied by the median nerve. Subsequently, real-time ultrasound guidance facilitated successful radial artery catheterization. Anatomical variations, such as the persistent median artery, can complicate radial artery catheterization and are not easily identified through pulse palpation alone. The use of vascular visualization devices is recommended to identify and navigate such variations, ensuring accurate catheter placement.

1 May 2018 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
TUTetsuya Uchino
Tetsuya Uchino
MMMasahiro Miura
Masahiro Miura
SMShigekiyo Matsumoto
Shigekiyo Matsumoto
CSChihiro Shingu
Chihiro Shingu
TKTakaaki Kitano
Takaaki Kitano

24 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YKYoshihide Kuribayashi
Yoshihide Kuribayashi
SMShigekiyo Matsumoto
Shigekiyo Matsumoto
YOYoshifumi Ohchi
Yoshifumi Ohchi
SKShinya Kai
Shinya Kai
YOYoshimasa Oyama
Yoshimasa Oyama
CSChihiro Shingu
Chihiro Shingu
Objectives: Oxidative stress after cardiac surgery may disrupt the blood–brain barrier and contribute to postoperative delirium (POD). Although associations between oxidative stress and POD are recognized, whether vitamin C (VC) can prevent POD remains poorly understood. This study aimed to explore the association of VC administration with POD after cardiac surgery. Methods: Eighty-four patients undergoing elective cardiac surgery at our hospital were enrolled. The non-VC group (NVC, n = 40) consisted of patients treated between October 2021 and March 2022, while the VC group (n = 44) included those treated between April and September 2022 who received 2 g intravenous VC at intensive care unit (ICU) admission. The primary outcome was POD incidence. Electron spin resonance (ESR) measured AFR/DMSO, which reflected VC before induction, after CPB withdrawal, at ICU admission, and on postoperative day 1. Results: Baseline characteristics, comorbidities, and intraoperative factors were similar between groups. Postoperative organ dysfunction and inflammation were also comparable, although lactate levels were 40% higher in the VC group. POD incidence was significantly lower with VC (35.0% vs. 11.4%, p < 0.01). Logistic regression analysis confirmed that VC reduced POD risk (adjusted odds ratio 0.22, 95% CI 0.07–0.69, p < 0.01). ESR showed that postoperative AFR/DMSO levels dropped sharply but normalized by day 1 in VC-treated patients. Conclusions: This study suggests that 2 g of VC administered at ICU admission may reduce POD incidence. In the future, these findings require confirmation in randomized trials.